FDA Approved: GIMOTI — Supplemental Application (Evoke Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for GIMOTI (metoclopramide hydrochloride) from Evoke Pharma, resulting in labeling updates approved under NDA 209388.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroparesis
• Nausea and Vomiting

Drugs mentioned

• GIMOTI (metoclopramide hydrochloride)

Snippet

SUPPL AP for GIMOTI (METOCLOPRAMIDE HYDROCHLORIDE)